Oyster Point Pharma, Inc. Operating Cash Flow
Oyster Point Pharma, Inc. reported Operating Cash Flow of -$124.51 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-11-10
- Oyster Point Pharma, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was -$35.97M.
- Oyster Point Pharma, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-06-30 was -$38.83M.
- Oyster Point Pharma, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was -$49.70M.
- Oyster Point Pharma, Inc. net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was -$41.49M.
- Oyster Point Pharma, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$89.37M.
- Oyster Point Pharma, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$58.40M.
- Oyster Point Pharma, Inc. net cash provided by (used in) operating activities for fiscal 2019 was -$40.81M.
- Oyster Point Pharma, Inc. net cash provided by (used in) operating activities for fiscal 2018 was -$17.08M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2022-09-30 | -$35.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$74.80M derived: sum of 2 quarters · filed 2022-11-10 | -$124.51M 10-Q · filed 2022-11-10 | -$166.00M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2022-06-30 | -$38.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$88.53M 10-Q · filed 2022-08-11 | -$130.02M derived: sum of 3 quarters · filed 2022-08-11 | -$140.82M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2022-03-31 | -$49.70M 10-Q · filed 2022-05-05 | -$91.19M derived: sum of 2 quarters · filed 2022-05-05 | -$101.99M derived: sum of 3 quarters · filed 2022-11-10 | -$122.55M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-12-31 | -$41.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$52.28M derived: sum of 2 quarters · filed 2022-11-10 | -$72.84M derived: sum of 3 quarters · filed 2022-11-10 | -$89.37M 10-K · filed 2022-02-24 | |
| 2021-09-30 | -$10.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$31.35M derived: sum of 2 quarters · filed 2022-11-10 | -$47.88M 10-Q · filed 2022-11-10 | -$47.90M 10-Q · filed 2021-11-04 | -$68.93M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$20.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$37.09M 10-Q · filed 2022-08-11 | -$58.14M derived: sum of 3 quarters · filed 2022-08-11 | -$70.39M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$16.53M 10-Q · filed 2022-05-05 | -$37.58M derived: sum of 2 quarters · filed 2022-05-05 | -$49.83M derived: sum of 3 quarters · filed 2022-05-05 | -$64.52M derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | -$21.05M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$33.30M derived: sum of 2 quarters · filed 2022-02-24 | -$47.99M derived: sum of 3 quarters · filed 2022-02-24 | -$58.40M 10-K · filed 2022-02-24 | |
| 2020-09-30 | -$12.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$26.94M derived: sum of 2 quarters · filed 2021-11-04 | -$37.35M 10-Q · filed 2021-11-04 | -$53.89M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-06-30 | -$14.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$25.10M 10-Q · filed 2021-08-05 | -$41.64M derived: sum of 3 quarters · filed 2021-08-05 | -$51.40M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | -$10.41M 10-Q · filed 2021-05-06 | -$26.95M derived: sum of 2 quarters · filed 2021-05-06 | -$36.71M derived: sum of 3 quarters · filed 2021-05-06 | -$47.80M derived: sum of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | -$16.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | -$26.30M derived: sum of 2 quarters · filed 2021-02-18 | -$37.38M derived: sum of 3 quarters · filed 2021-02-18 | -$40.81M 10-K · filed 2021-02-18 | |
| 2019-09-30 | -$9.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$20.85M derived: sum of 2 quarters · filed 2020-11-05 | -$24.28M 10-Q · filed 2020-11-05 | -$24.28M 10-Q · filed 2019-12-03 | -$28.32M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | -$11.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$14.52M 10-Q · filed 2020-08-05 | -$18.56M derived: sum of 3 quarters · filed 2020-08-05 | ||
| 2019-03-31 | -$3.43M 10-Q · filed 2020-05-11 | -$7.47M derived: sum of 2 quarters · filed 2020-05-11 | |||
| 2018-12-31 | -$4.04M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$17.08M 10-K · filed 2020-02-27 | |||
| 2018-09-30 | -$13.04M 10-Q · filed 2019-12-03 |